Therapy for Heparin-Induced Thrombocytopenia with Lepirudin (Refludan) in a Patient with Normal Renal Function


Allergy, Immunology, Anesthesiology, Cardiology, Dermatology, Endocrinology, Diabetes, Metabolism, Emergency Medicine, Family, General Practice, Geriatrics, Internal Medicine, Medical Genetics, Neurological Surgery, Neurology, Obstetrics, Gynecology, Oncology, Ophthalmology, Orthopedics, Otolaryngology, Pathology, Pediatrics, Physical Medicine and Rehabilitation, Plastic Surgery, Preventive Medicine, Psychiatry, Radiology, Surgery, Urology, Other




Lepirudin (Refludan) is a recombinant derivative of hirudin that is a direct thrombin inhibitor which is used as an anticoagulant in patients with heparin-induced thrombocytopenia. Hirudin was isolated initially from the salivary glands of medicinal leeches. It has a short half-life (about 1.3 hours in normal volunteers) and shows no cross-reactivity with anti-heparin antibodies. It is expensive, with a week's therapy costing thousands of dollars.

To read more or access our algorithms and calculators, please log in or register.


medal descover
medal iphone